A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.

Clinical trial NCT06075615 · WITHDRAWN

Trial details

NCT number: NCT06075615
Sponsor: Pfizer
Status: WITHDRAWN
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2024-09-30
Primary completion: 2026-09-07
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.